Abbott | ABT - Ebit




Abbott reported $2.66B in EBIT for its fiscal quarter ending in December of 2024.

Ebit Change Date
Abbott USD 2.66B 805M Dec/2024
Agilent USD 464M 32M Oct/2024
AtriCure USD -14523000 7.12M Dec/2024
Baxter International USD 391M 544M Sep/2024
Becton, Dickinson and Co. USD 1.43B 797M Sep/2024
Bio-Rad Laboratories USD 92.1M 18.81M Dec/2024
Boston Scientific USD 1.25B 104M Dec/2024
Cooper Companies USD 263.3M 7.2M Oct/2024
Danaher USD 1.93B 868M Dec/2024
Dexcom USD 209.5M 27.4M Dec/2024
Edwards Lifesciences USD 354.7M 70.9M Dec/2024
Globus Medical USD 144.67M 80.54M Sep/2024
Hologic USD 300.7M 4.2M Dec/2024
Insulet USD 88.1M 26M Sep/2024
Integra LifeSciences USD 51.52M 48.06M Sep/2024
Intuitive Surgical USD 927.7M 350.4M Dec/2024
J&J USD 5.35B 1.81B Dec/2024
Masimo USD 72.8M 41.9M Sep/2024
Medtronic USD 2.17B 128M Jan/2025
Merit Medical Systems USD 65.14M 11.61M Sep/2024
Pfizer USD 4.62B 2.42B Dec/2024
Smith & Nephew USD 471M 23M Jun/2024
Solventum Corp 475M 45M Sep/2024
Stryker USD 1.88B 521M Dec/2024
Tandem Diabetes Care USD -26093000 4.81M Sep/2024
Teleflex USD 157.11M 38.45M Sep/2024
Terumo JPY 35.57B 3.45B Mar/2024
Thermo Fisher Scientific USD 2.72B 358M Dec/2024
Zimmer Biomet Holdings USD 623.2M 143M Dec/2024